This Week in Cardiology Mar 21 2025 This Week in Cardiology
Mar 21, 2025
A recent trial sheds light on cardiac pacing and its implications for treatment strategies. The curious relationship between PVCs and cardiomyopathy is explored, challenging established norms. Cannabis use emerges as a contentious topic, revealing increased cardiovascular risks, yet the study's methodology is put under scrutiny. Listeners are invited to ponder the complexities of these findings while contemplating the future direction of research in cardiology.
AI Snips
Chapters
Transcript
Episode notes
Biopace Trial Insights
- The Biopace trial challenged the belief that Bi-V pacing is superior to RV pacing in all bradycardia patients.
- RV pacing may be less harmful for patients with preserved ejection fraction than previously thought.
Pacing Advice
- Reconsider the prevailing ideas that RV pacing is terrible and complex pacing is always better.
- Standard RV pacing is not obsolete, and more data on conduction system pacing is needed.
PVCs and Cardiomyopathy
- Over-treatment of PVCs is a significant issue in cardiology, potentially leading to unnecessary procedures.
- PVC burden alone may not be a reliable predictor of cardiomyopathy, challenging current treatment guidelines.